Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 6839 (MIR6839) is a small, non-coding RNA molecule found in humans, involved in the post-transcriptional regulation of gene expression. Specifically, the miR-6839-5p strand has been shown to inhibit the proliferation, migration, and invasion of human chondrosarcoma cells, as well as promote apoptosis by downregulating target genes such as Bcl-2, VEGFA, BST2, FPR3, and PPARA. MIR6839 likely contributes to tumor-suppressive pathways and is considered a regulatory RNA, not a classical drug target. It may serve as a biomarker for cellular processes or therapeutic response in specific cancers, but there are no approved drugs directly interacting with it at this time
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 6839 (MIR6839).